GCCAX
Price
$27.49
Change
-$0.47 (-1.68%)
Updated
Sep 11 closing price
Net Assets
570.76M
RSLCX
Price
$76.30
Change
+$0.25 (+0.33%)
Updated
Sep 11 closing price
Net Assets
91.39B
Interact to see
Advertisement

GCCAX vs RSLCX

GCCAX vs RSLCX Comparison Chart in %
View a ticker or compare two or three
VS
GCCAX vs. RSLCX commentary
Sep 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GCCAX is a Hold and RSLCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RSLCX has more cash in the bank: 91.4B vs. GCCAX (571M). GCCAX pays higher dividends than RSLCX: GCCAX (2.12) vs RSLCX (0.43). GCCAX was incepted earlier than RSLCX: GCCAX (7 years) vs RSLCX (24 years). RSLCX (1.30) is less costly to investors than GCCAX (0.81). GCCAX (41.00) and RSLCX (41.00) have comparable annual turnover. GCCAX has a lower initial minimum investment than RSLCX: GCCAX (0) vs RSLCX (250). GCCAX annual gain was more profitable for investors over the last year : 24.15 vs. RSLCX (8.36). RSLCX return over 5 years is better than : -11.31 vs. GCCAX (-14.44).
GCCAXRSLCXGCCAX / RSLCX
Total Expense Ratio0.781.3060%
Annual Report Gross Expense Ratio0.811.3062%
Fund Existence7 years24 years-
Gain YTD10.57112.07488%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets571M91.4B1%
Annual Yield % from dividends2.120.43494%
Returns for 1 year24.158.36289%
Returns for 3 years11.9635.9433%
Returns for 5 years-14.44-11.31128%
Returns for 10 yearsN/A75.60-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TXMD2.160.06
+2.86%
TherapeuticsMD
FSV137.781.77
+1.30%
FirstService Corp
AMN33.340.29
+0.88%
AMN Healthcare Services
PGR217.621.43
+0.66%
Progressive Corp
TBI8.75-0.31
-3.42%
Trueblue